SFX by Ex Libris Inc.

Title:	Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
Source:	Nature Medicine [1078-8956] LaFave, Lindsay yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Schoumacher, M. "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status." Nature Medicine 22.6 (2016): 577-578.
description	2.	Feng, Y. "A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance." Nature 528.7580 (2015): 132-136.
description	3.	Germain, Ronald N. "Immune homeostasis enforced by co-localized effector and regulatory T cells." Nature 528.7581 (2015): 225-30.
description	4.	van de Nes, Johannes A P A. "Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma." The American journal of surgical pathology 40.6 (2016): 796-805.
description	5.	Sastre Garau, X. "Ovarian cancers harboring inactivating mutations in CDK12 display a distinct genomic instability pattern characterized by large tandem duplications." Cancer research 76.7 (2016): 1882-1891.
description	6.	LaFave, Lindsay M. "Loss of BAP1 function leads to EZH2-dependent transformation." Nature medicine 21.11 (2015): 1344-9.
description	7.	Furney, Simon J. "SF3B1 mutations are associated with alternative splicing in uveal melanoma." Cancer discovery 3.10 (2013): 1122-1129.
description	8.	Ohkura, N. "T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development." Immunity 37.5 (2012): 785-799.
description	9.	Josefowicz, Steven Z. "Regulatory T Cells: Mechanisms of Differentiation and Function." Annual review of immunology 30.1 (2012): 531-564.
description	10.	van Santen, Hisse-Martien M. "Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells." The Journal of experimental medicine 200.10 (2004): 1221-30.
description	11.	Tian, S. "CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate." The journal of immunology 179.5 (2007): 2952-60.
description	12.	Bilate, Angelina M. "Induced CD4(+)Foxp3(+) Regulatory T Cells in Immune Tolerance." Annual review of immunology 30.1 (2011): 733-758.
description	13.	von Boehmer, H. "Mechanisms of suppression by suppressor T cells." Nature immunology 6.4: 338-344.
description	14.	Dutertre, M. "Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage." Nature Communications 7.1 (2016): 10615-10615.
description	15.	Gasteiger, G. "Tissue residency of innate lymphoid cells in lymphoid and non-lymphoid organs." Science 350.6263 (2015): 981-5.
description	16.	Thiault, N. "Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors." Nature Immunology 16.6 (2015): 628-634.
description	17.	Yarnell, K. "Domesticated horses differ in their behavioural and physiological responses to isolated and group housing." Physiology & behavior 143.C (2015): 51-57.
description	18.	Ziegler, Steven F. "FOXP3 and scurfy: how it all began." Nature reviews. Immunology 14.5 (2014): 343-349.
description	19.	Deniz, G. "Natural killer cells in patients with allergic diseases." Journal of allergy and clinical immunology 132.3 (2013): 527-535.
description	20.	Mauri, C. "Immune Regulatory Function of B Cells." Annual review of immunology 30.1 (2011): 221-241.